Shipments of Duchenne Gene Therapy to Resume After FDA Review of Patient Death

(MedPage Today) — Drugmaker Sarepta Therapeutics said it would resume shipping its gene therapy for some patients, following a brief pause requested by regulators.
The FDA said it recommended lifting the hold for young patients with Duchenne…

Source link : https://www.medpagetoday.com/publichealthpolicy/fdageneral/116714

Author :

Publish date : 2025-07-29 14:40:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

Shipments of Duchenne Gene Therapy to Resume After FDA Review of Patient Death

‘Where Is Our Voice?’

Hiding in Not-So-Plain Sight: AI Spots Interval Breast Cancers Missed on Mammography

Related Posts

Shopping addiction should be taken more seriously say sufferers

I’ve stopped life-saving medication says man exhausted by fight for NHS care

Transgender row rape charity starts new service for biological women

The doctor strike is ending

Updated Evidence Favors Structured Exercise Programs for Atrial Fibrillation

California bets on iron-salt battery power to protect against wildfire

Shopping addiction should be taken more seriously say sufferers

I’ve stopped life-saving medication says man exhausted by fight for NHS care

Transgender row rape charity starts new service for biological women

The doctor strike is ending

Updated Evidence Favors Structured Exercise Programs for Atrial Fibrillation

California bets on iron-salt battery power to protect against wildfire

Forests with robust animal populations store four times as much carbon

Can a Herpes Drug Slow Alzheimer’s?

Categories

Archives